发明名称 Injectable alloplastic implants and methods of use thereof
摘要 Described herein are injectable alloplastic implant compositions that are particularly useful for soft tissue defect augmentation. The compositions include microparticles, such as polymethylmethacrylate particles, and collagen as a suspending agent, wherein the collagen contains a reduced amount of low molecular weight gelatine compared to high molecular weight collagen. By controlling the molecular weight of the collagen in the compositions, the injectability, stability, and antigenicity of the alloplastic implant compositions can be improved.
申请公布号 US9370469(B2) 申请公布日期 2016.06.21
申请号 US201414211994 申请日期 2014.03.14
申请人 SUNEVA MEDICAL, INC 发明人 Masi Louis
分类号 A61K8/02;A61K8/65;A61F2/00;A61Q19/08;A61Q19/00;A61K9/00;A61K31/78;A61K47/42;A61L27/24;A61L27/48;C08L33/12 主分类号 A61K8/02
代理机构 Cantor Colburn LLP 代理人 Cantor Colburn LLP
主权项 1. A method of augmenting a soft tissue defect, comprising injecting an alloplastic implant composition near the soft tissue defect, wherein the alloplastic implant composition comprises denatured atelocollagen that has less than 10 wt % of the total weight as components of weight average molecular weight (Mw) 100,000 Daltons or lower, and greater than 70 wt % components of weight average molecular weight 100 kDa to 258 kDa, wherein the polydispersity of the denatured atelocollagen expressed as Mw/Mn is 1.0 to 1.6, wherein Mw is weight average molecular weight and Mn is number average molecular weight.
地址 San Diego CA US